NCT04751162 - A Study To Monitor Lung Cancer Patients Activity And Assess Performance Status Through A Wearable Device. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 18, 2021

Primary Completion Date

May 1, 2023

Study Completion Date

May 1, 2023

Conditions

Non-Small Cell Lung Cancer (NSCLC)

Interventions

DEVICE

Actigraphy device (wearable) and mobile application

Participants will be asked to wear an actigraphy device (wearable) and to install a mobile application on their smartphones (cf. Broderick et al., 2019) for tracking PA, SQ and symptoms for 3 weeks

Trial Locations (10)

17007

Hospital Universitari de Girona Dr Josep Trueta; Departamento de Oncologia Medica, Girona

18016

Hospital Universitario Clínico San Cecilio; Servicio de oncologia, Granada

28041

Hospital 12 de Octubre; Servicio de Digestivo, Madrid

28046

Hospital La Paz, Madrid

28922

Fundacion Hospital de Alcorcon, Alcorcón

30120

Hospital Universitario Virgen de Arrixaca; Servicio de Oncologia, Murcia

41013

Hospital Universitario Virgen del Rocio; Servicio de Oncologia, Seville

43003

Hospital Sant Pau i Santa Tecla; Servicio de Oncologia, Tarragona

46026

Hospital Universitario la Fe; Servicio de Oncologia, Valencia

08041

Hospital de la Santa Creu i Sant Pau; Servicio de Oncologia, Barcelona

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY